Central Garden & Pet updates FY2023 EPS guidance to $2.35 or better; Q2 EPS ~$0.90

CENTRAL GARDEN & PET CO

2023-Q2 EPS reported $0.74 revenue$1,536,667,000

FY2023 EPS guidance reaffirmed at $2.35 or better; Q2 EPS expected ~$0.90.
Q2 performance impacted by poor spring weather (severe storms, heavy rain, snow, cold).
Pet segment met expectations and gained market share; Garden segment soft due to late season.
Multi-year cost & simplicity program underway focused on procurement, logistics, manufacturing.
More details on the program during Q2 earnings call on May 3, 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CENTRAL GARDEN & PET CO reported the second quarter ended March 25, 2023 results: EPS approximately $0.90. Guidance reaffirmed.

Period: the second quarter ended March 25, 2023
EPS: approximately $0.90
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

Central Garden & Pet Company issued a press release reporting preliminary financial information for the second quarter ended March 25, 2023, and updating forward-looking guidance for the fiscal year ended September 30, 2023

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CENTRAL GARDEN & PET CO reported the fiscal year ended September 30, 2023 results: EPS $2.35 or better. Guidance raised.

Period: the fiscal year ended September 30, 2023
EPS: $2.35 or better
Guidance: raised
Result: guidance update

Exact text from the filing

the Company now expects fiscal 2023 earnings per share (“EPS”) to be $2.35 or better

View on SEC.gov

Browse all earnings releases →

CENTRAL GARDEN & PET CO filing history →

Source: SEC EDGAR

accession 0001157523-23-000572

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.